XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
XOMA Royalty (NASDAQ: XOMA) has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference, scheduled for February 11-12, 2025. The virtual event will feature a fireside chat with CEO Owen Hughes and CIO Brad Sitko on February 11, 2025, at 3:20 PM ET.
The presentation will be accessible through a dedicated link and through XOMA's investor relations website section. Interested parties can access the replay of the presentation, which will remain archived on the company's website for 90 days following the event.
XOMA Royalty (NASDAQ: XOMA) ha annunciato la sua partecipazione alla prossima 35ª Conferenza Annuale sulle Scienze della Vita Oppenheimer, prevista per l'11-12 febbraio 2025. L'evento virtuale includerà una chat informale con il CEO Owen Hughes e il CIO Brad Sitko l'11 febbraio 2025, alle 15:20 ET.
La presentazione sarà accessibile tramite un link dedicato e attraverso la sezione relazioni con gli investitori del sito web di XOMA. Le parti interessate potranno accedere alla registrazione della presentazione, che rimarrà archiviata sul sito della società per 90 giorni dopo l'evento.
XOMA Royalty (NASDAQ: XOMA) ha anunciado su participación en la próxima 35ª Conferencia Anual de Ciencias de la Salud de Oppenheimer, programada para el 11 y 12 de febrero de 2025. El evento virtual contará con una conversación informal con el CEO Owen Hughes y el CIO Brad Sitko el 11 de febrero de 2025, a las 15:20 ET.
La presentación será accesible a través de un enlace dedicado y a través de la sección de relaciones con inversores del sitio web de XOMA. Las partes interesadas podrán acceder a la grabación de la presentación, que permanecerá archivada en el sitio web de la compañía durante 90 días después del evento.
XOMA 로열티 (NASDAQ: XOMA)가 다가오는 오펜하이머 제35회 연례 헬스케어 생명과학 컨퍼런스에 참여할 것이라고 발표했습니다. 이 행사는 2025년 2월 11일부터 12일까지 예정되어 있으며, 2025년 2월 11일 오후 3시 20분 ET에 CEO 오웬 휴즈와 CIO 브래드 시트코의 대담이 진행됩니다.
발표는 전용 링크와 XOMA의 투자자 관계 웹사이트 섹션을 통해 접근할 수 있습니다. 관심 있는 분들은 행사 후 90일 동안 회사 웹사이트에 아카이브된 발표의 재생을 이용할 수 있습니다.
XOMA Royalty (NASDAQ: XOMA) a annoncé sa participation à la prochaine 35ème Conférence Annuelle sur la Santé et les Sciences de la Vie d'Oppenheimer, prévue pour les 11 et 12 février 2025. L'événement virtuel comportera une discussion avec le PDG Owen Hughes et le CIO Brad Sitko le 11 février 2025 à 15h20 ET.
La présentation sera accessible via un lien dédié et à travers la section relations investisseurs du site web de XOMA. Les parties intéressées pourront accéder à l'enregistrement de la présentation, qui restera archivé sur le site de l'entreprise pendant 90 jours après l'événement.
XOMA Royalty (NASDAQ: XOMA) hat seine Teilnahme an der bevorstehenden 35. jährlichen Oppenheimer-Konferenz für Gesundheits- und Lebenswissenschaften angekündigt, die für den 11. und 12. Februar 2025 geplant ist. Die virtuelle Veranstaltung wird am 11. Februar 2025 um 15:20 Uhr ET ein Gespräch mit CEO Owen Hughes und CIO Brad Sitko beinhalten.
Die Präsentation wird über einen speziellen Link und über den Bereich für Investorenkontakte der XOMA-Website zugänglich sein. Interessierte können die Aufzeichnung der Präsentation abrufen, die für 90 Tage nach der Veranstaltung auf der Unternehmenswebsite archiviert bleibt.
- None.
- None.
EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held virtually, February 11-12, 2025.
Owen Hughes, Chief Executive Officer, and Brad Sitko, Chief Investment Officer, will participate in a fireside chat on Tuesday, February 11, 2025 at 3:20 PM ET. The presentation can be assessed by visiting https://bit.ly/4jAMqQw.
XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com. A replay of each presentation will be available and archived on the site for 90 days after the event.
About XOMA Royalty Corporation
XOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA Royalty acquires the potential future economics associated with pre-commercial and commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA Royalty acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes. The Company has an extensive and growing portfolio of assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate). For more information about the Company and its portfolio, please visit www.xoma.com or follow XOMA Royalty Corporation on LinkedIn.
| XOMA Investor Contact Juliane Snowden XOMA Royalty +1 646-438-9754 juliane.snowden@xoma.com | XOMA Media Contact Kathy Vincent KV Consulting & Management +1 310-403-8951 kathy@kathyvincent.com |
FAQ
When is XOMA presenting at the Oppenheimer Healthcare Conference 2025?
How can investors access XOMA's Oppenheimer Conference presentation?
How long will XOMA's Oppenheimer Conference presentation be available for replay?
Which XOMA executives are participating in the Oppenheimer Healthcare Conference?
Is the Oppenheimer Healthcare Conference 2025 an in-person or virtual event?
